📰 Full Story
Chelsea winger Mykhailo Mudryk has lodged an appeal with the Court of Arbitration for Sport (CAS) against a four‑year suspension imposed by the Football Association after an “adverse finding” in a routine urine test.
CAS confirmed it received the appeal, filed on Feb. 25, 2026, and said parties are exchanging written submissions; a hearing has not been scheduled.
Mudryk, 25, was provisionally suspended in December 2024 and formally charged by the FA in June 2025.
British media and club sources say the substance involved is meldonium, detected after international duty with Ukraine in late 2024.
If the four‑year sanction is upheld and backdated to the provisional suspension, Mudryk would be ineligible to play until around December 2028; his lawyers hope a successful appeal could allow an earlier return.
The forward, signed from Shakhtar Donetsk in January 2023 for a fee reported up to £89m, has not played since November 2024 and has been training privately at non‑league Uxbridge FC. He is represented by Morgan Sports Law.
Chelsea and the FA declined to comment on the ongoing case.
Shakhtar have warned the outcome could cost them substantial performance‑related fees tied to the transfer.
🔗 Based On
🤝 Social Media Insights
Social Summary
Key points: meldonium is a banned recovery agent with a high‑profile precedent, and sporting authorities generally enforce domestic suspensions worldwide. Because CAS often reduces/backdates bans, the appeal could materially shorten Mudryk's absence and affect contracts and transfer payments.





💬 Commentary